Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Cardlytics ( (CDLX) ) has issued an announcement.
On May 20, 2025, Cardlytics held its Annual Meeting where stockholders voted on several key proposals. The election of three board nominees, the ratification of Deloitte & Touche LLP as the independent auditor, the approval of the 2025 Equity Incentive Plan, and the advisory approval of executive compensation were all passed with majority votes. This meeting reflects the company’s ongoing governance and strategic planning efforts, potentially impacting its operational and financial strategies moving forward.
The most recent analyst rating on (CDLX) stock is a Hold with a $4.00 price target. To see the full list of analyst forecasts on Cardlytics stock, see the CDLX Stock Forecast page.
Spark’s Take on CDLX Stock
According to Spark, TipRanks’ AI Analyst, CDLX is a Neutral.
Cardlytics’ overall stock score is 45, indicating a below-average performance largely due to financial challenges such as declining revenues, high leverage, and negative cash flow. While technical indicators show some positive momentum, the valuation remains unattractive with ongoing losses and no dividend yield. The recent earnings call highlighted mixed results with some strategic expansions but also significant revenue challenges and operational setbacks.
To see Spark’s full report on CDLX stock, click here.
More about Cardlytics
Average Trading Volume: 1,140,985
Technical Sentiment Signal: Sell
Current Market Cap: $104M
For an in-depth examination of CDLX stock, go to TipRanks’ Stock Analysis page.